» Articles » PMID: 24838297

Fibrin Network Architectures in Pure Platelet-rich Plasma As Characterized by Fiber Radius and Correlated with Clotting Time

Overview
Publisher Springer
Date 2014 May 20
PMID 24838297
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Fibrin networks are obtained through activation of platelet-rich plasma (PRP) for use in tissue regeneration. The importance of fibrin networks relies on mediation of release of growth factors, proliferation of tissue cells and rheological properties of the fibrin gels. Activation of PRP usually involves the decomposition of fibrinogen by agonists, in a wide range of concentrations. Therefore fibrin networks with a large structural diversity are formed, making comparative evaluations difficult. In order to standardize the fibrin networks, we used the statistical techniques central composite rotatable design and response-surface analysis, to correlate the radius of the fibers with the ratios between the agonists (autologous serum/calcium chloride) and agonist/PRP. From an individual and interactive analysis of the variables, architectures characterized by thick, medium and thin fibers were delineated on the response-surface. Furthermore, the architectures were correlated with coagulation time. This approach is valuable for standardizing the PRP preparation for clinical applications.

Citing Articles

The Implications of Brain-Derived Neurotrophic Factor in the Biological Activities of Platelet-Rich Plasma.

Franco Malange K, de Souza D, Borges Paes Lemes J, Fagundes C, Oliveira A, Pagliusi M Inflammation. 2024; 48(1):426-446.

PMID: 38904872 DOI: 10.1007/s10753-024-02072-9.


Nanofat Accelerates and Improves the Vascularization, Lymphatic Drainage and Healing of Full-Thickness Murine Skin Wounds.

Limido E, Weinzierl A, Ampofo E, Harder Y, Menger M, Laschke M Int J Mol Sci. 2024; 25(2).

PMID: 38255932 PMC: 10815416. DOI: 10.3390/ijms25020851.


Characterization and Safety Profile of a New Combined Advanced Therapeutic Medical Product Platelet Lysate-Based Fibrin Hydrogel for Mesenchymal Stromal Cell Local Delivery in Regenerative Medicine.

Canceill T, Jourdan G, Kemoun P, Guissard C, Monsef Y, Bourdens M Int J Mol Sci. 2023; 24(3).

PMID: 36768532 PMC: 9916739. DOI: 10.3390/ijms24032206.


The role of VEGF, PDGF and IL-6 on diabetic foot ulcer after Platelet Rich Fibrin + hyaluronic therapy.

Kartika R, Alwi I, Suyatna F, Yunir E, Waspadji S, Immanuel S Heliyon. 2021; 7(9):e07934.

PMID: 34585000 PMC: 8455691. DOI: 10.1016/j.heliyon.2021.e07934.


Centrifugation Conditions in the L-PRP Preparation Affect Soluble Factors Release and Mesenchymal Stem Cell Proliferation in Fibrin Nanofibers.

Gomes de Melo B, Luzo A, Santos Duarte Lana J, Santana M Molecules. 2019; 24(15).

PMID: 31357568 PMC: 6696255. DOI: 10.3390/molecules24152729.


References
1.
Zhao H, Ma L, Zhou J, Mao Z, Gao C, Shen J . Fabrication and physical and biological properties of fibrin gel derived from human plasma. Biomed Mater. 2008; 3(1):015001. DOI: 10.1088/1748-6041/3/1/015001. View

2.
Dohan Ehrenfest D, Rasmusson L, Albrektsson T . Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol. 2009; 27(3):158-67. DOI: 10.1016/j.tibtech.2008.11.009. View

3.
Carr Jr M, Gabriel D, McDonagh J . Influence of Ca2+ on the structure of reptilase-derived and thrombin-derived fibrin gels. Biochem J. 1986; 239(3):513-6. PMC: 1147316. DOI: 10.1042/bj2390513. View

4.
Wolberg A . Thrombin generation and fibrin clot structure. Blood Rev. 2007; 21(3):131-42. DOI: 10.1016/j.blre.2006.11.001. View

5.
Weisel J . Fibrinogen and fibrin. Adv Protein Chem. 2005; 70:247-99. DOI: 10.1016/S0065-3233(05)70008-5. View